Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs.
González-Correa C, Moleón J, Miñano S, Robles-Vera I, Toral M, Barranco AM, Martín-Morales N, O'Valle F, Guerra-Hernández E, Sánchez M, Gómez-Guzmán M, Jiménez R, Romero M, Duarte J. González-Correa C, et al. Among authors: romero m. Br J Pharmacol. 2024 May 21. doi: 10.1111/bph.16410. Online ahead of print. Br J Pharmacol. 2024. PMID: 38770714
Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes.
Miró Ò, Núñez J, Trullàs JC, Lopez-Ayala P, Llauger L, Alquézar-Arbé A, Miñana G, Mollar A, de la Espriella R, Lorenzo M, Jacob J, Espinosa B, Garcés-Horna V, Aguirre A, Fortuny MJ, Martínez-Nadal G, Gil V, Mueller C, Llorens P; ICA-SEMES; INCLIVA; ALCALOTIC research groups. Miró Ò, et al. Eur J Intern Med. 2024 May 18:S0953-6205(24)00213-9. doi: 10.1016/j.ejim.2024.05.009. Online ahead of print. Eur J Intern Med. 2024. PMID: 38763846
Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure.
Puente A, Fortea JI, Del Pozo C, Serrano M, Alonso-Peña M, Giráldez A, Tellez L, Martinez J, Magaz M, Ibañez L, Garcia J, Llop E, Alvarez-Navascues C, Romero M, Rodriguez E, Arias Loste MT, Antón A, Echavarria V, López C, Albillos A, Hernández-Gea V, Garcia-Pagán JC, Bañares R, Crespo J; by REHEVASC group. Puente A, et al. Among authors: romero m. Dig Liver Dis. 2024 May 7:S1590-8658(24)00711-4. doi: 10.1016/j.dld.2024.04.010. Online ahead of print. Dig Liver Dis. 2024. PMID: 38719628
Strategies to enhance the response of liver cancer to pharmacological treatments.
Marin JJG, Macias RIR, Asensio M, Romero MR, Temprano AG, Pereira OR, Jimenez S, Mauriz JL, Di Giacomo S, Avila MA, Efferth T, Briz O. Marin JJG, et al. Among authors: romero mr. Am J Physiol Cell Physiol. 2024 May 6. doi: 10.1152/ajpcell.00176.2024. Online ahead of print. Am J Physiol Cell Physiol. 2024. PMID: 38708523 Review.
2,318 results